As shown in Table 2, patients had significantly increased inflammatory markers such as CRP (230 mg/L, IQR 154–304), procalcitonin (1.7 μg/L, IQR 0.28–8.97), IL-6 (239.47 pg/mL, IQR 97.99–859.22), and fibrinogen (6.1 g/L, IQR 5.1–8.17), as well as leukocytosis and neutrophilia (WBC of 14.1 × 109/L, IQR 10.1–18.45 and neutrophils of 12.2 × 109/L, IQR 8.4–15.6). The gene discussed is IL6; the disease is Increased total leukocyte count.